comparemela.com
Home
Live Updates
Japan govt averting criticism with early inoculation for small number of elderly in mid-April : comparemela.com
Japan gov't averting criticism with early inoculation for small number of elderly in mid-April
news
Japan gov't averting criticism with early inoculation for small number of elderly in mid-April
The Mainichi
© The Mainichi
A COVID-19 vaccination drill takes place at the Shibukawa civic hall in Gunma Prefecture on Feb. 24, 2021. (Mainichi/Tetsuya Shoji)
TOKYO -- While priority vaccinations against the coronavirus will start for elderly people aged 65 and older in some parts of Japan on April 12, it appears that the number of those to receive the vaccine will remain very low in the early stages.
There are no prospects of a stable supply of COVID-19 vaccines from overseas, and it is estimated that full-scale vaccinations for elderly individuals nationwide will begin in the week starting on April 26. The Japanese government has taken particular care to begin inoculations during the month of April to avoid criticism over the slight delay from the originally scheduled start to vaccinations for the elderly on April 1 at the earliest, amid a rise in the public's interest and expectations surrounding the vaccine.
Related Keywords
Gunma
,
Gumma
,
Japan
,
Tokyo
,
Shibukawa
,
Okayama
,
Japanese
,
Yusuke Tanabe
,
Mainichi Tetsuya Shoji
,
Pfizer
,
Constitutional Democratic Party Of Japan
,
Cabinet Office
,
European Union
,
House Of Representatives Budget Committee
,
Political News Department
,
Gunma Prefecture
,
Tetsuya Shoji
,
Administrative Reform Taro Kono
,
Yuichi Goto
,
Constitutional Democratic Party
,
Representatives Budget Committee
,
துப்பாக்கி
,
கும்மா
,
ஜப்பான்
,
டோக்கியோ
,
ஷிபுகாவா
,
ஒக்யமா
,
ஜப்பானிய
,
யூசுக்கே தனபெ
,
ஃபைசர்
,
அரசியலமைப்பு ஜனநாயக கட்சி ஆஃப் ஜப்பான்
,
மந்திரி சபை அலுவலகம்
,
ஐரோப்பிய தொழிற்சங்கம்
,
வீடு ஆஃப் பிரதிநிதிகள் பட்ஜெட் குழு
,
பொலிடிகல் செய்தி துறை
,
துப்பாக்கி ப்ரீஃபெக்சர்
,
அரசியலமைப்பு ஜனநாயக கட்சி
,
பிரதிநிதிகள் பட்ஜெட் குழு
,
comparemela.com © 2020. All Rights Reserved.